Efficacy and tolerability of vaginal progesterone capsules (Utrogest™ 200) compared with progesterone gel (Crinone™ 8%) for luteal phase support during assisted reproduction
- 30 June 2005
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 83 (6) , 1641-1649
- https://doi.org/10.1016/j.fertnstert.2004.11.073
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Luteal phase support using either Crinone® 8% or Utrogest®: results of a prospective, randomized studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
- A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cyclesFertility and Sterility, 2001
- Crinone® vaginal gel vs. intramuscular progesterone for luteal support in oocyte donation cycles: clinical and endocrinologic difference.Fertility and Sterility, 2001
- Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase supportActa Obstetricia et Gynecologica Scandinavica, 2001
- Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal womenFertility and Sterility, 2000
- Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cyclesFertility and Sterility, 1999
- Use of Crinone∗ vaginal progesterone gel for luteal support in in vitro fertilization cyclesFertility and Sterility, 1999
- Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transferFertility and Sterility, 1999
- Intrahepatic cholestasis of pregnancy: A French prospective studyHepatology, 1997
- Luteal Phase SupportSeminars in Reproductive Medicine, 1995